Depression

>

Latest News

Key Advances in Mental Health Research in 2025 for Primary Care
Key Advances in Mental Health Research in 2025 for Primary Care

December 16th 2025

Gus Alva, MD, reviews key 2025 psychiatry advances, including non-monoaminergic approaches to MDD and newer targets in schizophrenia care.

FDA Clears First At-Home Brain-Stimulation Device for Major Depression / image source: Flow Therapeutics
FDA Clears First At-Home Brain-Stimulation Device for Major Depression

December 11th 2025

Smartphone Ownership in Young Adolescence Drives Physical and Emotional Health Risks, Study Finds / image credit ©itsmejust/stock.adobe.com
Smartphone Ownership in Young Adolescence Drives Physical and Emotional Health Risks

December 5th 2025

Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care / image credit ©fizkes/stock.adobe.com
Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care

December 1st 2025

Atopic Dermatitis Management Beyond Skin Symptoms in Primary Care / image credit ©Monkey Business/stock.adobe.com
Atopic Dermatitis Management Beyond Skin Symptoms in Primary Care

November 27th 2025

More News


Site Logo

Effective Pharmacological Treatment Options for Anxiety Disorders

March 1st 2008

Cumulative research with animal, normative, and clinical populations over several decades shows that the mechanisms underlying anxiety disorders differ from those of the normal emotion of anxiety. In persons with anxiety disorders, fear and tension are disproportionate to the actual threat and may be present when no real threat exists, thereby generating an expectation of danger and distorted perceptions related to danger and various types of threats. The most common anxiety disorders are social anxiety disorder (SAD), generalized anxiety disorder (GAD), and posttraumatic stress disorder (PTSD). Persons with SAD can experience a wide range of social fears as well as severe functional consequences, whereas persons with GAD tend to experience emotional, interpersonal, and somatic symptoms of high levels of chronic anxiety. Persons with PTSD have vivid memories of and thoughts about a terrifying event or ordeal that lead to the development of anxiety, depression, and functional impairment. Effective treatment options-pharmacotherapy; psychotherapy, particularly cognitive-behavioral therapy; or a combination-can be discussed openly with the patient to make a collaborative, informed decision. A variety of medications can be used to successfully manage anxiety disorders, of which SSRIs and serotonin-norepinephrine reuptake inhibitors are the most effective. When properly used, medications can enhance a patient's own efforts to master anxiety; overcome fearful avoidance; and address troubling behaviors, patterns, or memories. (Drug Benefit Trends. 2008;20:101-113)

© 2025 MJH Life Sciences

All rights reserved.